-- 
4SC’s Experimental Hodgkin’s Lymphoma Drug Awarded Orphan Status

-- B y   A n g e l a   C u l l e n
-- 
2011-09-26T05:33:07Z

-- http://www.bloomberg.com/news/2011-09-26/4sc-s-experimental-hodgkin-s-lymphoma-drug-awarded-orphan-status.html
4SC AG (VSC)  said U.S. regulators granted
orphan drug status to the experimental Hodgkin’s Lymhoma drug
Resminostat.  To contact the editor responsible for this story:
Angela Cullen at 
 acullen8@bloomberg.net  